Ceva Launches Gabbrovet® Multi to Treat scour in calves

Ceva Animal Health has launched NEW Gabbrovet® Multi, which is now the first and only ready to use solution licensed to treat both cryptosporidium and E.Coli diarrhoea in calves1.

Cryptosporidiosis is the most common cause of neonatal diarrhoea in calves under one month of age2, while E.Coli is considered the second most important pathogen affecting calves on UK farms3. Neonatal diarrhoea not only contributes to increased mortality, reduced growth rate4, 5, delayed age at first calving and decreased milk production6, but contact with infected livestock has been found to be the source of human cryptosporidium in up to 38% of cases7.

Gabbrovet Multi contains paramomycin as its active ingredient and replaces Gabbrovet® Solution. In a study8 of 334 calves with severe diarrhoea, those receiving Gabbrovet Multi showed a faster and more effective response than those given halofuginone.

“Gabbrovet Multi is the first and only ready to use solution for the convenient treatment of both cryptosporidium and E.Coli, two of the most common causes of neonatal scour in calves,” comments Harry Walby, ruminant veterinary advisor at Ceva Animal Health. “Alongside Gabbrovet Multi, Ceva also has a wide range of products to support the management of calves with scour including Meloxidyl®, Rehydion® and Diarsanyl®.”

Gabbrovet Multi can be administered in milk or water. The ready to use solution is available with a dosing cap and it comes in 250ml, 500ml or 1l presentations.

For further information on Gabbrovet Multi, which also treats gastro-intestinal infections caused by E.Coli in pigs, contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.